2018
DOI: 10.1007/s12020-018-1756-4
|View full text |Cite
|
Sign up to set email alerts
|

The relationship between anti-Müllerian hormone serum level and body mass index in a large cohort of infertile patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
29
1
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(34 citation statements)
references
References 36 publications
2
29
1
2
Order By: Relevance
“…But in patients >35 years old, no correlation found in bivariate analysis or after adjustment for age in a multivariate linear regression model. However, the age of the patients was negatively associated with serum AMH level in all age groups after adjustment for BMI and this is the same we have in our study [24] .…”
Section: Discussionsupporting
confidence: 89%
“…But in patients >35 years old, no correlation found in bivariate analysis or after adjustment for age in a multivariate linear regression model. However, the age of the patients was negatively associated with serum AMH level in all age groups after adjustment for BMI and this is the same we have in our study [24] .…”
Section: Discussionsupporting
confidence: 89%
“…Albu reported that BMI was not significantly correlated with AMH in a cohort of infertile patients which was similar to our results. But when the association between AMH serum level and BMI was analyzed according to age group, AMH and BMI were positively correlated in young patients (≤ 30 years old and 30-35 years old, r = 0.139, p = 0.021 and r = 0.077, p = 0.027, respectively) [18]. However, Bernardi et al, reported that BMI at the age of 18 (β=-0.016; 95% CI -0.024, -0.008), which is considered the heaviest reported lifetime weight (β=-0.002; 95% CI -0.003, -0.001) was inversely associated with AMH.…”
Section: Discussionmentioning
confidence: 93%
“…AMH levels have been observed to be higher in obese PCOS versus non-PCOS female adolescents of comparable age and puberty, and thus AMH level may be a useful biomarker for PCOS diagnosis in obese female adolescents (32). Additionally, there is increasing interest in a further putative role for AMH in the pathogenesis of PCOS, acting as an endocrine signal to directly increase gonadotropin-releasing hormone pulse (33,34). Limitation of our study include the need for larger numbers in both groups, i.e., PCOS and non-PCOS patients.…”
Section: Discussionmentioning
confidence: 99%